These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32555031)

  • 1. Report of 2 Pediatric Cases With Li-Fraumeni Syndrome Related Malignancy in a Family.
    Takeoka M; Toyoda H; Hirayama J; Suzuki N; Hanaki R; Amano K; Iwamoto S; Hirayama M
    J Pediatr Hematol Oncol; 2021 May; 43(4):e567-e570. PubMed ID: 32555031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome.
    Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH
    Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 Tetramerization domain mutations: germline R342X and R342P, and somatic R337G identified in pediatric patients with Li-Fraumeni syndrome and a child with adrenocortical carcinoma.
    Fiszer-Maliszewska L; Kazanowska B; Padzik J;
    Fam Cancer; 2009; 8(4):541-6. PubMed ID: 19714490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 germline mutations in adult patients with adrenocortical carcinoma.
    Herrmann LJ; Heinze B; Fassnacht M; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E476-85. PubMed ID: 22170717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A rhabdomyosarcoma patient from a Li-Fraumeni syndrome family: a case report and literature review].
    Xie Y; Zhao WH; Hua Y; Sun Q; Wu PH
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Dec; 19(12):1263-1266. PubMed ID: 29237527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5th International ACC Symposium: Hereditary Predisposition to Childhood ACC and the Associated Molecular Phenotype: 5th International ACC Symposium Session: Not Just for Kids!
    Else T; Rodriguez-Galindo C
    Horm Cancer; 2016 Feb; 7(1):36-9. PubMed ID: 26660147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
    Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H
    Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
    Macedo GS; Vieira IA; Vianna FSL; Alemar B; Giacomazzi J; Brandalize APC; Caleffi M; Volc SM; de Campos Reis Galvão H; Palmero EI; Achatz MI; Ashton-Prolla P
    Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
    Mai PL; Best AF; Peters JA; DeCastro RM; Khincha PP; Loud JT; Bremer RC; Rosenberg PS; Savage SA
    Cancer; 2016 Dec; 122(23):3673-3681. PubMed ID: 27496084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations.
    Choong SS; Latiff ZA; Mohamed M; Lim LL; Chen KS; Vengidasan L; Razali H; Abdul Rahman EJ; Ariffin H;
    Clin Genet; 2012 Dec; 82(6):564-8. PubMed ID: 22233476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SEOM clinical guideline on heritable TP53-related cancer syndrome (2022).
    Sánchez-Heras AB; Ramon Y Cajal T; Pineda M; Aguirre E; Graña B; Chirivella I; Balmaña J; Brunet J;
    Clin Transl Oncol; 2023 Sep; 25(9):2627-2633. PubMed ID: 37133731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation.
    Yamazaki F; Shima H; Osumi T; Narumi S; Kuroda T; Shimada H
    J Pediatr Hematol Oncol; 2018 Apr; 40(3):e195-e197. PubMed ID: 28902083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.
    Sorrell AD; Espenschied CR; Culver JO; Weitzel JN
    Mol Diagn Ther; 2013 Feb; 17(1):31-47. PubMed ID: 23355100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.
    Raymond VM; Else T; Everett JN; Long JM; Gruber SB; Hammer GD
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E119-25. PubMed ID: 23175693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Adrenocortical Carcinoma and Neuroblastoma in an Infant With a Novel Germline p53 Mutation.
    Courtney R; Ranganathan S
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):215-8. PubMed ID: 25374282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
    Kamihara J; Rana HQ; Garber JE
    Hum Mutat; 2014 Jun; 35(6):654-62. PubMed ID: 24706533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V
    Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.